Authors: Leung, NWY Lai, CL Chang, TT Guan, R Lee, CM Ng, KY Lim, SG Wu, PC Dent, JC Edmundson, S Condreay, LD Chien, RN

Citation: Nwy. Leung et al., Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy, HEPATOLOGY, 33(6), 2001, pp. 1527-1532

Authors: Aoki, FY Fleming, DM Griffin, AD Lacey, LA Edmundson, S

Citation: Fy. Aoki et al., Impact of zanamivir treatment on productivity, health status and healthcare resource use in patients with influenza, PHARMACOECO, 17(2), 2000, pp. 187-195

Authors: Liaw, YF Leung, NWY Chang, TT Guan, R Tai, DI Ng, KY Chien, RN Dent, J Roman, L Edmundson, S Lai, CL

Citation: Yf. Liaw et al., Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B, GASTROENTY, 119(1), 2000, pp. 172-180

Authors: Webster, A Boyce, M Edmundson, S Miller, I

Citation: A. Webster et al., Coadministration of orally inhaled zanamivir with inactivated trivalent influenza vaccine does not adversely affect the production of antihaemagglutinin antibodies in the serum of healthy volunteers, CLIN PHARMA, 36, 1999, pp. 51-58